A. I. Tomaz

发表

Important cytotoxicity of novel iron(II) cyclopentadienyl complexes with imidazole based ligands.

T. Morais, F. Marques, I. Santos, 2013, Journal of inorganic biochemistry.

Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes

T. Morais, M. Bicho, F. Marques, 2014, JBIC Journal of Biological Inorganic Chemistry.

Ruthenium‐Based Anticancer Compounds: Insights into Their Cellular Targeting and Mechanism of Action

P. Zinck, T. Morais, M. Bicho, 2017 .

Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.

M. Comini, D. Gambino, T. Morais, 2015, Journal of inorganic biochemistry.

Antitumour and Toxicity Evaluation of a Ru(II)-Cyclopentadienyl Complex in a Prostate Cancer Model by Imaging Tools.

T. Jorge, T. Morais, L. Gano, 2019, Anti-cancer agents in medicinal chemistry.

Interaction with Blood Proteins of a Ruthenium(II) Nitrofuryl Semicarbazone Complex: Effect on the Antitumoral Activity

D. Gambino, F. Marques, L. Otero, 2019, Molecules.

A new ruthenium cyclopentadienyl azole compound with activity on tumor cell lines and trypanosomatid parasites

M. Comini, M. Vieites, D. Gambino, 2015 .

[RuII(η⁵-C₅H₅)(bipy)(PPh₃)]⁺, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin.

T. Kiss, J. Pessoa, T. Jakusch, 2012, Journal of Inorganic Biochemistry.

Ruthenium and iron metallodrugs: new inorganic and organometallic complexes as prospective anticancer agents

T. Morais, M. Garcia, A. Valente, 2021, Synthetic Inorganic Chemistry.

Cellular Uptake Mechanisms of an Antitumor Ruthenium Compound: The Endosomal/Lysosomal System as a Target for Anticancer Metal-Based Drugs

T. Morais, M. Bicho, F. Marques, 2013, Microscopy and Microanalysis.

RuII( p-cymene) Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo.

A. R. Fernandes, Jesús J Fernández, Alberto Fernández, 2018, Inorganic chemistry.

Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.

V. Moreno, J. Lorenzo, D. Gambino, 2013, Dalton transactions.

New ternary Fe(III)-8-hydroxyquinoline-reduced Schiff base complexes as selective anticancer drug candidates.

V. Ferretti, J. Pessoa, I. León, 2022, Journal of inorganic biochemistry.

V(IV)O and Cu(II) complexation by ligands based on pyridine nitrogen donors.

G. Micera, D. Sanna, E. Garribba, 2012, Dalton transactions.

New polydentate Ru(III)-Salan complexes: Synthesis, characterization, anti-tumour activity and interaction with human serum proteins

J. Pessoa, F. Marques, I. Santos, 2013 .

DNA cleavage activity of V IV O(acac)2 and derivatives.

V. Moreno, J. P. Telo, Sofia Gama, 2009, Journal of inorganic biochemistry.

Studies on the mechanism of action of antitumor bis(aminophenolate) ruthenium(III) complexes.

T. Kiss, F. Marques, R. F. D. de Almeida, 2017, Journal of inorganic biochemistry.

Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.

T. Morais, F. Marques, A. Valente, 2016, Future medicinal chemistry.

The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds.

F. Marques, F. Avecilla, Tiago J. L. Silva, 2015, Journal of inorganic biochemistry.

The effect of phosphate on the nuclease activity of vanadium compounds.

J. Pinheiro, J. P. Da Silva, I. Correia, 2015, Journal of inorganic biochemistry.

Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies

A. R. Fernandes, P. Baptista, L. Martins, 2014, JBIC Journal of Biological Inorganic Chemistry.

Interaction of vanadium(IV) with human serum apo-transferrin.

M. Romão, T. Kiss, Somnath Roy, 2013, Journal of Inorganic Biochemistry.

May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?

O. Cevik, F. Pavan, J. Pessoa, 2019, European journal of medicinal chemistry.

New ternary iron(iii) aminobisphenolate hydroxyquinoline complexes as potential therapeutic agents.

F. Pavan, J. Pessoa, I. Correia, 2019, Dalton transactions.

Effect of the metal ion on the anti T. cruzi activity and mechanism of action of 5-nitrofuryl-containing thiosemicarbazone metal complexes

B. Garat, D. Gambino, J. Maya, 2014 .

Thiolate-S as anchoring donor in the binary and ternary VO(IV) complexes of mercaptopropionylglycine

T. Kiss, J. Pessoa, T. Jakusch, 2002 .

Uptake and metabolic effects of insulin mimetic oxovanadium compounds in human erythrocytes.

C. Geraldes, John G. Jones, I. Correia, 2005, Journal of inorganic biochemistry.

Unprecedented collateral sensitivity for cisplatin-resistant lung cancer cells presented by new ruthenium organometallic compounds

D. Belisario, C. Riganti, I. Romero, 2021, Inorganic Chemistry Frontiers.

Ruthenium(II) polypyridyl complexes with benzothiophene and benzimidazole derivatives: Synthesis, antitumor activity, solution studies and biospeciation.

G. Spengler, R. F. D. de Almeida, F. Avecilla, 2022, Journal of inorganic biochemistry.

Anticancer activity of structurally related ruthenium(II) cyclopentadienyl complexes

T. Morais, M. Bicho, F. Marques, 2014, JBIC Journal of Biological Inorganic Chemistry.

Assessing the role of membrane lipids in the action of ruthenium(III) anticancer compounds

M. L. Corvo, R. F. D. de Almeida, R. Starosta, 2023, Frontiers in Molecular Biosciences.

Fighting Multidrug Resistance with Ruthenium-Cyclopentadienyl Compounds: Unveiling the Mechanism of P-gp Inhibition.

C. Riganti, I. Romero, X. Fontrodona, 2023, Journal of medicinal chemistry.

Evaluation of the Antiproliferative Properties of CpRu Complexes Containing N-Methylated Triazaphosphaadamantane Derivatives

A. Romerosa, Franco Scalambra, A. Valente, 2023, Bioinorganic chemistry and applications.

Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies

A. R. Fernandes, P. Baptista, L. Martins, 2014, JBIC Journal of Biological Inorganic Chemistry.

Novel family of [RuCp(N,N)(P)]+ compounds with simultaneous anticancer and antibacterial activity: Biological evaluation and solution chemistry studies.

I. Romero, X. Fontrodona, M. Vasconcelos, 2023, European journal of medicinal chemistry.